Journal Report

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Download PDF
Journal Information
Journal Title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Publisher
WILEY
ISSN
0269-2813
E-ISSN
1365-2036
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Letter: Advanced Therapies for <scp>PSC</scp> ‐ <scp>IBD</scp> : A Persistent Scarcity of Data
Badr Al‐Bawardy, Mohammed Nabil Quraishi
2026-11-14
DOI: 10.1111/apt.71098
Carbon Footprint of Diagnostic Modalities Used in Inflammatory Bowel Disease Care: The <scp>EVERGREEN</scp> ‐ <scp>IBD</scp> Study (EVERGREEN‐IBD: Evaluating Value, Emissions, Resource Use, and GREEN diagnostics in IBD)
Hardik Rughwani, Rupa Banerjee, Rajendra Patel et al.
2026-11-13
DOI: 10.1111/apt.71091
Letter: More Than the Sum of Its Parts—What Does ALBI Add to Interleukin‐6?
Junao Chen, Zihan Yu
2026-11-13
DOI: 10.1111/apt.71095
Editorial: Not All Fibres Are Created Equal—Fibre Supplements for Personalised Application. Authors' Reply
Neele Dellschaft, Joshua E. S. J. Reid, Gleb Yakubov et al.
2026-11-7
DOI: 10.1111/apt.71064
Letter: Anticoagulation After Gastrointestinal Bleeding—Prognostic Associations are not Treatment Effects
Kunal Mahajan, Abdul Basit, Anshul Yadav
2026-11-6
DOI: 10.1111/apt.71092
Editorial: Microscopic Colitis—Are Medications Linked to Disease or Disease Investigation?
David Bergman, Jonas W. Wastesson, Jonas F. Ludvigsson
2026-11-5
DOI: 10.1111/apt.71086
Editorial: When It Comes to Gastrointestinal Bleeding, It's Not the Anticoagulant Therapy Itself That's the Problem, but How It's Being Managed
Marc Bardou, Thomas Mouillot, Théophile Gerster
2026-11-5
DOI: 10.1111/apt.71089
Editorial: Objective Follow Up of Inflammation After Therapy for Eosinophilic Oesophagitis
Stephen E. Attwood
2026-11-5
DOI: 10.1111/apt.71093
Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ <scp>TNF</scp> Effectiveness in Inflammatory Bowel Disease: An <scp>ENEIDA</scp> Registry Study’
Bhumesh Tyagi, Parag J. Ratnakar, Hima Bindu Mantravadi et al.
2026-11-4
DOI: 10.1111/apt.70944
Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in <scp>IBD</scp> —Is This the Time for Model Informed Precision Dosing?
Benjamin Mecsas‐Faxon, Konstantinos Papamichael, Adam S. Cheifetz
2026-11-4
DOI: 10.1111/apt.71087
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 14, 2026 15:11